Glycosaminoglycan-based hybrid hydrogel encapsulated with polyelectrolyte complex nanoparticles for endogenous stem cell regulation in central nervous system regeneration

Wei Hong Jian, Huan Chih Wang, Chen Hsiang Kuan, Ming Hong Chen, Hsi Chin Wu, Jui Sheng Sun, Tzu Wei Wang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The poor regenerative capability of stem cell transplantation in the central nervous system limits their therapeutic efficacy in brain injuries. The sustained inflammatory response, lack of structural support, and trophic factors deficiency restrain the integration and long-term survival of stem cells. Instead of exogenous stem cell therapy, here we described the synthesis of nanohybrid hydrogel containing sulfated glycosaminoglycan-based polyelectrolyte complex nanoparticles (PCN) to mimic the brain extracellular matrix and control the delivery of stromal-derived factor-1α (SDF-1α) and basic fibroblast factor (bFGF) in response to matrix metalloproteinase (MMP) for recruiting endogenous neural stem cells (NSC) and regulating their cellular fate. Bioactive factors are delivered by electrostatic sequestration on PCN to amplify the signaling of SDF-1α and bFGF to regulate NSC in vitro. In in vivo ischemic stroke model, the factors promoted neurological behavior recovery by enhancing neurogenesis and angiogenesis. These combined strategies may be applied for other tissue regenerations by regulating endogenous progenitors through the delivery of different kinds of glycosaminoglycan-binding molecules.

Original languageEnglish
Pages (from-to)17-30
Number of pages14
JournalBiomaterials
Volume174
DOIs
Publication statusPublished - Aug 2018
Externally publishedYes

Fingerprint

Neural Stem Cells
Hydrogel
A73025
Neurology
Glycosaminoglycans
Stem cells
Polyelectrolytes
Hydrogels
Nanoparticles
Regeneration
Stem Cells
Central Nervous System
Neurogenesis
Stem Cell Transplantation
Cell- and Tissue-Based Therapy
Static Electricity
Matrix Metalloproteinases
Brain Injuries
Extracellular Matrix
Fibroblasts

Keywords

  • Brain
  • Glycosaminoglycan
  • Growth factors
  • Hydrogel
  • Neural stem cell
  • Polyelectrolyte complex nanoparticle

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Glycosaminoglycan-based hybrid hydrogel encapsulated with polyelectrolyte complex nanoparticles for endogenous stem cell regulation in central nervous system regeneration. / Jian, Wei Hong; Wang, Huan Chih; Kuan, Chen Hsiang; Chen, Ming Hong; Wu, Hsi Chin; Sun, Jui Sheng; Wang, Tzu Wei.

In: Biomaterials, Vol. 174, 08.2018, p. 17-30.

Research output: Contribution to journalArticle

Jian, Wei Hong ; Wang, Huan Chih ; Kuan, Chen Hsiang ; Chen, Ming Hong ; Wu, Hsi Chin ; Sun, Jui Sheng ; Wang, Tzu Wei. / Glycosaminoglycan-based hybrid hydrogel encapsulated with polyelectrolyte complex nanoparticles for endogenous stem cell regulation in central nervous system regeneration. In: Biomaterials. 2018 ; Vol. 174. pp. 17-30.
@article{24551ab244cf469ca3a5aa3f9950e680,
title = "Glycosaminoglycan-based hybrid hydrogel encapsulated with polyelectrolyte complex nanoparticles for endogenous stem cell regulation in central nervous system regeneration",
abstract = "The poor regenerative capability of stem cell transplantation in the central nervous system limits their therapeutic efficacy in brain injuries. The sustained inflammatory response, lack of structural support, and trophic factors deficiency restrain the integration and long-term survival of stem cells. Instead of exogenous stem cell therapy, here we described the synthesis of nanohybrid hydrogel containing sulfated glycosaminoglycan-based polyelectrolyte complex nanoparticles (PCN) to mimic the brain extracellular matrix and control the delivery of stromal-derived factor-1α (SDF-1α) and basic fibroblast factor (bFGF) in response to matrix metalloproteinase (MMP) for recruiting endogenous neural stem cells (NSC) and regulating their cellular fate. Bioactive factors are delivered by electrostatic sequestration on PCN to amplify the signaling of SDF-1α and bFGF to regulate NSC in vitro. In in vivo ischemic stroke model, the factors promoted neurological behavior recovery by enhancing neurogenesis and angiogenesis. These combined strategies may be applied for other tissue regenerations by regulating endogenous progenitors through the delivery of different kinds of glycosaminoglycan-binding molecules.",
keywords = "Brain, Glycosaminoglycan, Growth factors, Hydrogel, Neural stem cell, Polyelectrolyte complex nanoparticle",
author = "Jian, {Wei Hong} and Wang, {Huan Chih} and Kuan, {Chen Hsiang} and Chen, {Ming Hong} and Wu, {Hsi Chin} and Sun, {Jui Sheng} and Wang, {Tzu Wei}",
year = "2018",
month = "8",
doi = "10.1016/j.biomaterials.2018.05.009",
language = "English",
volume = "174",
pages = "17--30",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier Science Ltd",

}

TY - JOUR

T1 - Glycosaminoglycan-based hybrid hydrogel encapsulated with polyelectrolyte complex nanoparticles for endogenous stem cell regulation in central nervous system regeneration

AU - Jian, Wei Hong

AU - Wang, Huan Chih

AU - Kuan, Chen Hsiang

AU - Chen, Ming Hong

AU - Wu, Hsi Chin

AU - Sun, Jui Sheng

AU - Wang, Tzu Wei

PY - 2018/8

Y1 - 2018/8

N2 - The poor regenerative capability of stem cell transplantation in the central nervous system limits their therapeutic efficacy in brain injuries. The sustained inflammatory response, lack of structural support, and trophic factors deficiency restrain the integration and long-term survival of stem cells. Instead of exogenous stem cell therapy, here we described the synthesis of nanohybrid hydrogel containing sulfated glycosaminoglycan-based polyelectrolyte complex nanoparticles (PCN) to mimic the brain extracellular matrix and control the delivery of stromal-derived factor-1α (SDF-1α) and basic fibroblast factor (bFGF) in response to matrix metalloproteinase (MMP) for recruiting endogenous neural stem cells (NSC) and regulating their cellular fate. Bioactive factors are delivered by electrostatic sequestration on PCN to amplify the signaling of SDF-1α and bFGF to regulate NSC in vitro. In in vivo ischemic stroke model, the factors promoted neurological behavior recovery by enhancing neurogenesis and angiogenesis. These combined strategies may be applied for other tissue regenerations by regulating endogenous progenitors through the delivery of different kinds of glycosaminoglycan-binding molecules.

AB - The poor regenerative capability of stem cell transplantation in the central nervous system limits their therapeutic efficacy in brain injuries. The sustained inflammatory response, lack of structural support, and trophic factors deficiency restrain the integration and long-term survival of stem cells. Instead of exogenous stem cell therapy, here we described the synthesis of nanohybrid hydrogel containing sulfated glycosaminoglycan-based polyelectrolyte complex nanoparticles (PCN) to mimic the brain extracellular matrix and control the delivery of stromal-derived factor-1α (SDF-1α) and basic fibroblast factor (bFGF) in response to matrix metalloproteinase (MMP) for recruiting endogenous neural stem cells (NSC) and regulating their cellular fate. Bioactive factors are delivered by electrostatic sequestration on PCN to amplify the signaling of SDF-1α and bFGF to regulate NSC in vitro. In in vivo ischemic stroke model, the factors promoted neurological behavior recovery by enhancing neurogenesis and angiogenesis. These combined strategies may be applied for other tissue regenerations by regulating endogenous progenitors through the delivery of different kinds of glycosaminoglycan-binding molecules.

KW - Brain

KW - Glycosaminoglycan

KW - Growth factors

KW - Hydrogel

KW - Neural stem cell

KW - Polyelectrolyte complex nanoparticle

UR - http://www.scopus.com/inward/record.url?scp=85048027053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048027053&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2018.05.009

DO - 10.1016/j.biomaterials.2018.05.009

M3 - Article

C2 - 29763775

AN - SCOPUS:85048027053

VL - 174

SP - 17

EP - 30

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -